I. Duncan

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.

D. Cruickshank, S. M. Crawford, S. Kaye, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised study comparing standard dose carboplatin with chlorambucil and carboplatin in advanced ovarian cancer.

D. Cruickshank, S. Kaye, S. Kaye, 1992, British Journal of Cancer.

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

D. Cruickshank, S. M. Crawford, S. Kaye, 1992, The Lancet.

A pilot study of carboplatin (JM8, CBDCA) and chlorambucil in combination for advanced ovarian cancer.

S. Kaye, M. Harding, A. Maclean, 1988, British Journal of Cancer.

Drug resistance in ovarian cancer — the role of p53

I. Cree, R. Petty, A. Evans, 2008, Pathology & Oncology Research.

A randomised comparison of treosulfan and carboplatin in patients with ovarian cancer: a study by the Scottish Gynaecological Cancer Trials Group (SGCTG).

C. Poole, S. Kaye, J. Graham, 2006, European journal of cancer.

Survival after Ovarian Granulosa and Theca Cell Tumours

J. Dempster, I. Duncan, R. Geirsson, 1987, Scottish medical journal.